Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : BXRX crawled time : 12:00 save search
Baudax Bio Announces Corporate Update
Published: 2023-10-18 (Crawled : 12:00) - globenewswire.com
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: 25.86%
H: 1.16%
C: -18.31%
update
Baudax Bio Announces Orphan Drug Designation Granted by U.S. FDA for TI-168 for the Treatment of Hemophilia A with Inhibitors
Published: 2023-09-28 (Crawled : 12:00) - globenewswire.com
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: 87.57%
H: 38.62%
C: -19.67%
ti-168 fda drug granted treatment designation
Baudax Bio to Participate in the H.C. Wainwright Global Investment Conference
Published: 2023-09-07 (Crawled : 12:00) - globenewswire.com
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: 1.04%
H: 2.56%
C: 1.28%
conference global
Baudax Bio Announces Distribution of Series C Preferred Stock to Holders of its Common Stock
Published: 2023-08-23 (Crawled : 12:00) - globenewswire.com
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: 6.03%
H: 0.0%
C: -4.53%
distribution
Baudax Bio Announces $1.9 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
Published: 2023-08-17 (Crawled : 12:00) - globenewswire.com
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: -6.11%
H: 5.53%
C: 0.4%
nasdaq direct offering
Baudax Bio Reports Second Quarter 2023 Financial Results and Provides Business Update
Published: 2023-08-16 (Crawled : 12:00) - globenewswire.com
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: -3.48%
H: 0.0%
C: 0.0%
business update financial results
Baudax Bio Acquires TeraImmune, Inc.
Published: 2023-06-30 (Crawled : 12:00) - globenewswire.com
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: 23.03%
H: 123.42%
C: 82.81%
Baudax Bio Reports 2021 Fourth Quarter and Annual Financial Results
Published: 2022-03-16 (Crawled : 12:00) - globenewswire.com
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: 3.09%
H: 5.69%
C: 4.19%
financial results report results
Baudax Bio to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference
Published: 2021-11-15 (Crawled : 12:00) - globenewswire.com
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: 2.71%
H: 0.0%
C: -4.08%
conference
Baudax Bio to Report Third Quarter 2021 Financial Results and Host Conference Call and Webcast on November 4, 2021
Published: 2021-10-28 (Crawled : 12:00) - biospace.com/
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: 0.5%
H: 3.98%
C: -0.25%
financial results results conference
Baudax Bio to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
Published: 2021-09-07 (Crawled : 12:00) - biospace.com/
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: -0.2%
H: 0.9%
C: -0.16%
conference
Baudax Bio Reports Second Quarter 2021 Financial Results and Highlights
Published: 2021-08-05 (Crawled : 12:00) - biospace.com/
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: -1.93%
H: 1.39%
C: -5.08%
financial results results
Baudax Bio to Participate in the JMP Securities Life Sciences Conference
Published: 2021-06-10 (Crawled : 12:00) - biospace.com/
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: -1.14%
H: 3.51%
C: -2.38%
life science conference
Baudax Bio’s ANJESO® Achieves Formulary Listing at Over 100 Institutions in Less Than One Year on the Market
Published: 2021-06-08 (Crawled : 12:00) - biospace.com/
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: 3.41%
H: 2.16%
C: -1.81%
Baudax Bio Announces Publication of Phase IIIb ANJESO® Data in the Journal Pain Management
Published: 2021-05-17 (Crawled : 12:00) - biospace.com/
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: 1.22%
H: 6.61%
C: 2.22%
Baudax Bio Reports First Quarter 2021 Financial Results
Published: 2021-05-05 (Crawled : 12:00) - biospace.com/
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: -3.81%
H: 4.3%
C: -10.1%
financial results results
Baudax Bio Announces Publication of Phase IIIb Data on Preoperative Administration of ANJESO® in Patients Undergoing Total Knee Arthroplasty (TKA) in Pain Medicine
Published: 2021-04-26 (Crawled : 12:00) - biospace.com/
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: 1.87%
H: 6.42%
C: 5.5%
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.